Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT02562898 · COMPLETED
Trial details
- NCT number
- NCT02562898
- Sponsor
- Margaret Tempero
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-12
- Primary completion
- 2019-11-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.